StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive:

Enter Symbol or Keywords

Nine Year High in EBITDA for GTC Biotherapeutics

Stock Quote: (N/A:GTCB)

08/06/2010

0.00

N/A

Nine Year High in EBITDA for GTC Biotherapeutics

Last

Price Change

% Chg

Volume

New York, NY, August 6, 2010-Ebitda News reports that negative EBITDA for GTC Biotherapeutics, Inc. (OTC:GTCB) for its quarter ended June 30, 2010 was $(798,000), a 91% improvement over the year earli ... read full story

Website Address:
Industry:

Most Recent STN Exclusives

11/04/2010

Cash Flow from Operations for SAP AG Reaches Nine Year High

11/04/2010

Macrovision Solutions' OPS Ranking of "2" Reiterated by StockDiagnostics.com

11/04/2010

Cash Flow from Operations for Pepco Holdings Reaches Four Year High

11/04/2010

Cash Flow from Operations Increases 151% for KLA-Tencor

11/04/2010

Seven Year High in Cash Flow from Operations for Dana Holding

11/04/2010

Public Service Enterprise's Cash Flow from Operations Increases 48%

11/04/2010

StockDiagnostics.com Reiterates Schlumberger Limited's OPS Ranking of "1"

11/04/2010

Free Cash Flow Turns Negative for Goodyear's Third Quarter

11/04/2010

Cash Flow from Operations for Waste Management Increases 17.7%

11/04/2010

Free Cash Flow for America Movil Reaches Three Year High

Interactive Chart: GTCB

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: GTCB

08/06/2010

Nine Year High in EBITDA for GTC Biotherapeutics

08/05/2010

T12-NEWS reports that the Revenue of GTC Biotherapeutics for its 12 month ended June 30, 2010 Increased by 50.13%

08/04/2010

GTC Biotherapeutics' OPS Ranking of "8" Reiterated by StockDiagnostics.com

... more GTCB exclusives

Other News Sources: GTCB

05/20/2011

GTC Biotherapeutics, Inc., a LFB Group Company, Granted Protection until 2027 on Broad Transgenic Protein Production Patent, and is Also Granted New Patent on Recombinant Anti-Thrombin Produced Transgenically

12/06/2010

Acquisition of GTC Biotherapeutics, Inc. by LFB Biotechnologies S.A.S. Completed

11/08/2010

GTC Biotherapeutics, Inc. Agrees to Be Taken Private for $.30 Per Share

... more GTCB news from other sources

Daily Market Updates

02/03/2012

Markets Rally Today Following Strong January Jobs Report

U.S. markets rallied today following the release of a positive January employment report. The Nasdaq Composite hit at an 11-year high and the Dow closed at its highest level in 3 1/2 years after the report showed that the U.S. economy added 243,000 n ... read full story